New grant opportunity on Grants.gov: Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)

Funding Opportunity ID: 326081 Opportunity Number: RFA-AI-20-026 Opportunity Title: Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed) Opportunity Category: Discretionary Opportunity Category Explanation: Funding Instrument Type: Cooperative Agreement Category of Funding Activity: Health Category Explanation: CFDA Number(s): 93.855 Eligible Applicants: Public and State controlled institutions of higher education Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details. Agency Code: HHS-NIH11 Agency Name: Department of Health and Human Services National Institutes of Health Posted Date: Apr 06, 2020 Close Date: Jul 17, 2020 Last Updated Date: Apr 06, 2020 Award Ceiling: $11,500,000 Award Floor: $0 Estimated Total Program Funding: $23,000,000 Expected Number of Awards: 2 Description: The goal of this Funding Opportunity Announcement (FOA) is to continue to provide operations support for Biosafety Level 4 (BSL4) facilities to the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs will serve as a national resource for efforts in conducting pre-clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs biodefense and emerging infectious diseases research efforts. Additionally, in times of a national biodefense or emerging infectious disease (EID) emergency, the NBLs may be expected to rapidly realign their activities to assist response efforts within the US under the direction of NIAID. Version: 1

Published at: June 04, 2020 at 05:45AM